Cite

HARVARD Citation

    Mizandari, M. et al. (2017). Long-term survival in a patient with low-level inflammatory markers and liver metastasis, converted resectable by TACE. Immunotherapy. pp. 1067-1069. [Online]. 
  
Back to record